Tagged Articles

hormone treatment 3 articles

Endocrine Society calls for larger assessment of risks with testosterone therapy

Just days after the Food and Drug Administration (FDA) announced it was investigating the safety of testosterone replacement treatments, the U.S. Endocrine Society called for a fuller assessment of the risks and benefits associated with the hormone treatment. The actions follow two new studies that raised serious concerns about the risks of testosterone therapy in older men. One study showed that men who used testosterone supplements were significantly more likely to have a heart attack in the first 90 days after starting the treatment. A second study found that older men who used the treatment were nearly 30 percent more ... Read More

FDA approves Pfizer’s new hormone treatment for hot flashes, prevention of osteoporosis

The Food and Drug Administration (FDA) has approved Duavee, Pfizer’s new hormone treatment for menopause-related hot flashes in women who have not had a hysterectomy, and to prevent osteoporosis in post-menopausal women. Duavee is the first FDA-approved drug that combines a mixture of estrogens with another compound, bazedoxifene, which acts like estrogen to protect bone density. The FDA rejected bazedoxifene as an osteoporosis treatment in 2009 after numerous delays based on concerns that the drug could increase the risk for strokes and blood clots. Duavee enters a profitable market that already includes Hisamitsu Pharmaceutical Co.’s Brisdelle and Eli Lilly & ... Read More

FDA approves new breast cancer fighting drug

A new drug has been approved by the Food and Drug Administration (FDA) to aid in the fight against breast cancer. Perjeta (pertuzumab), made by Genentech, was approved in combination with Herceptin (trastuzumab) and docetaxel chemotherapy for the treatment of HER2-positive metastatic breast cancer in people who have not received prior anti-HER2 therapy or chemotherapy for metastatic breast cancer. HER2-positive breast cancer is a breast cancer that tests positive for a protein called human epidermal growth factor receptor 2, which promotes the growth of cancer cells. In about 1 of every 5 breast cancers, the cancer cells make an excess ... Read More